ASLAN Pharmaceuticals Ltd (ASLN)
0.4008
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
0.42
+0.02
(+4.79%)
After-Hours: 20:00
ASLAN Pharmaceuticals Enterprise Value: 17.21M for June 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 17.21M |
| June 12, 2024 | 17.46M |
| June 11, 2024 | 17.41M |
| June 10, 2024 | 17.62M |
| June 07, 2024 | 17.62M |
| June 06, 2024 | 18.48M |
| June 05, 2024 | 18.92M |
| June 04, 2024 | 18.39M |
| June 03, 2024 | 18.50M |
| May 31, 2024 | 17.82M |
| May 30, 2024 | 17.85M |
| May 29, 2024 | 17.87M |
| May 28, 2024 | 18.19M |
| May 24, 2024 | 18.73M |
| May 23, 2024 | 18.30M |
| May 22, 2024 | 18.33M |
| May 21, 2024 | 18.98M |
| May 20, 2024 | 19.41M |
| May 17, 2024 | 18.16M |
| May 16, 2024 | 17.96M |
| May 15, 2024 | 17.17M |
| May 14, 2024 | 17.17M |
| May 13, 2024 | 17.31M |
| May 10, 2024 | 17.42M |
| May 09, 2024 | 17.62M |
| Date | Value |
|---|---|
| May 08, 2024 | 17.23M |
| May 07, 2024 | 17.45M |
| May 06, 2024 | 17.72M |
| May 03, 2024 | 18.24M |
| May 02, 2024 | 18.52M |
| May 01, 2024 | 18.46M |
| April 30, 2024 | 18.53M |
| April 29, 2024 | 18.46M |
| April 26, 2024 | 17.52M |
| April 25, 2024 | 18.26M |
| April 24, 2024 | 18.75M |
| April 23, 2024 | 18.73M |
| April 22, 2024 | 18.41M |
| April 19, 2024 | 19.70M |
| April 18, 2024 | 20.34M |
| April 17, 2024 | 19.23M |
| April 16, 2024 | 19.24M |
| April 15, 2024 | 19.55M |
| April 12, 2024 | 19.44M |
| April 11, 2024 | 20.34M |
| April 10, 2024 | 20.14M |
| April 09, 2024 | 21.02M |
| April 08, 2024 | 20.56M |
| April 05, 2024 | 20.34M |
| April 04, 2024 | 19.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-25.88M
Minimum
Jun 07 2022
284.02M
Maximum
Mar 18 2021
52.53M
Average
42.47M
Median
Oct 08 2021
Enterprise Value Benchmarks
| Dr Reddy's Laboratories Ltd | 11.32B |
| Concord Medical Services Holdings Ltd | 995.33M |
| Zai Lab Ltd | 1.340B |
| WAVE Life Sciences Ltd | 612.62M |
| CytoMed Therapeutics Ltd | 17.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.920M |
| Total Expenses (Quarterly) | 9.291M |
| EPS Diluted (Quarterly) | -0.50 |
| Earnings Yield | -465.2% |
| Normalized Earnings Yield | -777.11 |